Quebec City – October 16, 2026 -- Devonian Health Group Inc. (TSXV: GSD; OTCQB: DVHGF) has not set a revised trading start date or closing date for its planned U.S. initial public offering on the NYSE American, according to its third update on the process since July 27, 2026.
Devonian keeps ThinkEquity on the NYSE American IPO preparations
The company said it continues to work with ThinkEquity on the steps needed to complete the offering and list its common shares and warrants on the NYSE American. The proposed ticker symbols are "DHGR" for the shares and "DHGR WS" for the warrants.
The latest statement follows earlier updates dated August 18, 2026, and September 11, 2026. Devonian said it will announce the revised trading and closing dates by press release once they are determined.
NYSE American and TSX Venture Exchange approvals remain outstanding
The offering and listing depend on market conditions and on regulatory approvals, including those of NYSE American LLC and the TSX Venture Exchange. Devonian cautioned that there is no assurance the offering will be completed, or that its timing, size or final terms will hold if it proceeds.
Devonian remains listed on the TSXV. The company also said no securities will be offered or sold to investors residing in Quebec or elsewhere in Canada in connection with the offering.
The registration statement for the offering has been filed with the U.S. Securities and Exchange Commission, according to the company's risk disclosure.